COVID-19 infections in sarcoidosis: a prospective single center study of 886 sarcoidosis patients

COVID-19 infections in sarcoidosis: a prospective single center study of 886 sarcoidosis patients

Authors

  • Robert P. Baughman Editor-in-chief, Sarcoidosis, Vasculitis and Diffuse Lung Diseases
  • Elyse E. Lower Department of Medicine, University of Cincinnati Medical Center, Cincinnati, OH, USA

Keywords:

COVID, sarcoidosis, COVID-19, herpes zoster, opportunistic infections

Abstract

.

References

(1) Dureault A, Chapelon C, Biard L et al. Severe infections in sarcoidosis: Incidence, predictors and long-term outcome in a cohort of 585 patients. Medicine (Baltimore) 2017; 96(49):e8846.

(2) Baughman RP, Lower EE. Fungal infections as a complication of therapy for sarcoidosis. QJM 2005; 98:451-456.

(3) Bernard C, Maucort-Boulch D, Varron L et al. Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases. QJM 2013; 106(6):523-539.

(4) Morgenthau AS, Levin MA, Freeman R et al. Moderate or Severe Impairment in Pulmonary Function is Associated with Mortality in Sarcoidosis Patients Infected with SARS-CoV-2. Lung 2020;10-00392.

(5) Jeny F, Lhote R, Lorillon G et al. Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'. Ann Rheum Dis 2020;annrheumdis-218957.

(6) Manansala M, Ascoli C, Alburquerque AG et al. Case Series: COVID-19 in African American Patients With Sarcoidosis. Front Med (Lausanne) 2020; 7:588527. doi: 10.3389/fmed.2020.588527. eCollection@2020.:588527.

(7) Baughman RP, Lower EE, Buchanan M et al. Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire. Sarcoidosis Vasc Diffuse Lung Dis 2020; 37(4):e2020009.

(8) Crouser ED, Maier LA, Wilson KC et al. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2020; 201(8):e26-e51.

(9) Gianfrancesco M, Hyrich KL, Al-Adely S et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 2020; 79(7):859-866.

(10) Aksoy S, Harputluoglu H, Kilickap S et al. Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma 2007; 48(7):1307-1312.

Downloads

Published

28-06-2021

Issue

Section

Letter to Editor

How to Cite

1.
Baughman RP, Lower EE. COVID-19 infections in sarcoidosis: a prospective single center study of 886 sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2021 Jun. 28 [cited 2025 May 21];38(2):e2021029. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/11646